Blood Transfusion - 2 2011 (April - June)
Intra-operative cell salvage: a fresh look at the indications and contraindications
 
Authors:  Stephen A. Esper, Jonathan H. Waters
Pages:  139-147
To cite this article:  Blood Transfus 2011;9:139-47
Doi:  10.2450/2011.0081-10
Published online:  13/01/2011

Preview
Introduction
Numerous approaches are used to avoid transfusion of allogeneic blood. Primary methods include, but are not limited to, erythropoietin and iron supplementation, pre-operative autologous donation, acute normovolaemic haemodilution, haemoglobin-based blood substitutes and infusible oxygen-carrying fluids, and the use of cell salvage systems. While currently unavailable in North America and Europe because of an increased risk of myocardial infarction and death1,2, research continues in the areas of haemoglobin-based blood substitutes and infusible oxygen-carrying liquids.
Of the accepted strategies mentioned above, cell salvage offers the medical community a safe, resource-saving, and relatively inexpensive method to avoid allogeneic red cell transfusion. Currently, incorrect information and misconceptions regarding the use of cell salvage systems frequently portray them as expensive, ineffective, and inappropriate for use in certain clinical situations. In addition to addressing these misconceptions, this article will discuss indications and contraindications for the use of such systems (...).
  
Full Text Download Back
       
Share this article: